Cases of iatrogenic Creutzfeldt-Jakob Disease (CJD) can be reduced by taking a number of careful steps.
The majority of cases of CJD reported from around the world (454 of 469) involve either use of dura mater or human growth hormone.
Source
Measure to Prevent Infection
dura mater
use of low risk, nondural tissue or synthetic material
growth hormone or other pituitary hormones
development of recombinant hormones
instrument-related
careful decontamination procedures
blood product transfusion
deferral of potentially infected donors
coagulation factor prepared from pooled plasma
development of recombinant coagulation factor
corneal and other tissue transplants
careful screening of donors
To read more or access our algorithms and calculators, please log in or register.
Specialty: Infectious Diseases
ICD-10: ,
